Alprazolam as an antidepressant.

Abstract

Alprazolam appears to be an effective antidepressant in the treatment of outpatients who have a diagnosis of major depressive disorder. The authors have reviewed six controlled double-blind studies of alprazolam in the treatment of depression. Four of the six studies included only outpatients and clearly demonstrated a clinical effectiveness comparable to that of the tricyclics but with fewer, less severe side effects and better tolerance. The other two studies involved both inpatients and outpatients, so no conclusions can be drawn regarding the effectiveness of alprazolam in an inpatient population; further controlled studies are needed to answer this question. No satisfactory explanation exists for the mechanism of alprazolam's proposed antidepressant action.

• Authors: M D Warner, C A Peabody, H A Whiteford, L E Hollister
• Journal: The Journal of clinical psychiatry (J Clin Psychiatry) Vol. 49 Issue 4 Pg. 148-50 (Apr 1988) ISSN: 0160-6689 [Print] United States
• PMID: 3281931 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Review)

Chemical References

• Antidepressive Agents, Tricyclic
• Alprazolam

Topics

• Alprazolam (adverse effects, therapeutic use)
• Ambulatory Care
• Antidepressive Agents, Tricyclic (adverse effects, therapeutic use)
• Clinical Trials as Topic
• Depressive Disorder (drug therapy, psychology)
• Double-Blind Method
• Hospitalization
• Humans